Closing the case of APOE in multiple sclerosis: No association with disease risk in over 29 000 subjects

Journal of Medical Genetics

Volumn 49, Issue 9, 2012, Pages 558-562

  Lill, Christina M ^a,b   Liu, Tian ^b,c   Schjeide, Brit Maren M ^b   Roehr, Johannes T ^b   Akkad, Denis A ^d   Damotte, Vincent ^e   Alcina, Antonio ^f   Ortiz, Miguel A ^g   Arroyo, Rafa ^g   de Lapuente, Aitzkoa Lopez ^h   Blaschke, Paul ⁱ   Winkelmann, Alexander ⁱ   Gerdes, Lisa Ann ^j   Luessi, Felix ^a   Fernadez, Oscar ^k   Izquierdo, Guillermo ^k   Antigüedad, Alfredo ^l   Hoffjan, Sabine ^d   Cournu Rebeix, Isabelle ^e   Gromöller, Silvana ^b   Faber, Hans ^m   Liebsch, Maria ^b   Meissner, Esther ^b   Chanvillard, Coralie ⁿ   Touze, Emmanuel ^o   Pico, Fernando ^p   Corcia, Philippe ^q   Dörner, Thomas ^r   Steinhagen Thiessen, Elisabeth ^r   Baeckman, Lars ^s   Heekeren, Hauke R ^c,t   Li, Shu Chen ^c   Lindenberger, Ulman ^c   Chan, Andrew ^d   Hartung, Hans Peter ^u   Aktas, Orhan ^u   Lohse, Peter ^j   Kümpfel, Tania ^j   Kubisch, Christian ^v   Epplen, Joerg T ^d   Zettl, Uwe K ⁱ   Fontaine, Bertrand ^e,k   Vandenbroeck, Koen ^h,w   Matesanz, Fuencisla ^f   Urcelay, Elena ^g   Bertram, Lars ^b   Zipp, Frauke ^a   Bahlo, Melanie ^x   Booth, David R ^y   Broadley, Simon A ^z,aa   Brown, Matthew A ^ab,ac   Browning, Brian L ^ad   Browning, Sharon R ^ad   Butzkueven, Helmut ^ae,af   Carroll, William M ^ag,ah   Cox, Mathew B ^ai,aj   Chapman, Caron ^ak   Clarke, Glynnis ^al   Danoy, Patrick ^ab   Drysdale, Karen ^am   Field, Judith ^ae   Foote, Simon J ^am   Greer, Judith M ^an   Griffiths, Lyn R ^z   Jensen, Cathy J ^ae   Johnson, Laura J ^ae   Kermode, Allan G ^ag,ah   Heard, Robert N ^y   Kilpatrick, Trevor J ^ae,ao   Lechner Scott, Jeanette ^ai,ap   Marriott, Mark ^ao   Mason, Deborah ^aq   Moscato, Pablo ^ai,aj   Pender, Michael P ^ab,ar   Perreau, Victoria M ^ae   Rubio, Justin P ^ae   Scott, Rodney J ^ai,aj,ap   Slee, Mark ^as   Stankovich, Jim ^an   Stewart, Graeme J ^y   Tajouri, Lotfi ^z   Taylor, Bruce V ^an   Wiley, James ^at   Wilkins, Ella J ^ae   more..

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^c MAX PLANCK INSTITUTE FOR HUMAN DEVELOPMENT   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^g HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^h UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

ⁱ UNIVERSITY OF ROSTOCK   (Germany)

^j UNIVERSITY OF MUNICH   (Germany)

^k HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^l HOSPITAL DE BASURTO   (Spain)

^m MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

ⁿ MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^o CENTRE HOSPITALIER SAINTE ANNE   (France)

^p CENTRE HOSPITALIER DE VERSAILLES   (France)

^q UNIVERSITY HOSPITAL OF TOURS   (France)

^r CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^s KAROLINSKA INSTITUTE   (Sweden)

^t FREIE UNIVERSITÄT BERLIN   (Germany)

^u Department of Orthopedic Surgery   (Germany)

^v UNIVERSITY OF ULM   (Germany)

^w BASQUE FOUNDATION FOR SCIENCE   (Spain)

^x WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^y WESTMEAD HOSPITAL   (Australia)

^z GRIFFITH UNIVERSITY   (Australia)

^aa GOLD COAST UNIVERSITY HOSPITAL   (Australia)

^ab UNIVERSITY OF QUEENSLAND   (Australia)

^ac UNIVERSITY OF OXFORD   (United Kingdom)

^ad UNIVERSITY OF AUCKLAND   (New Zealand)

^ae UNIVERSITY OF MELBOURNE   (Australia)

^af BOX HILL HOSPITAL   (Australia)

^ag SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^ah Australian Neuromuscular Research Institute   (Australia)

^ai HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^aj UNIVERSITY OF NEWCASTLE   (Australia)

^ak BARWON HEALTH   (Australia)

^al UNIVERSITY OF OTAGO   (New Zealand)

^am UNIVERSITY OF TASMANIA   (Australia)

^an UNIVERSITY OF QUEENSLAND   (Australia)

^ao ROYAL MELBOURNE HOSPITAL   (Australia)

^ap JOHN HUNTER HOSPITAL   (Australia)

^aq CANTERBURY DISTRICT HEALTH BOARD   (New Zealand)

^ar ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^as FLINDERS UNIVERSITY   (Australia)

^at NEPEAN HOSPITAL   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ARTICLE; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84870262595     PISSN: 00222593     EISSN: 14686244     Source Type: Journal    
DOI: 10.1136/jmedgenet-2012-101175     Document Type: Article

References (11)

1. Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, de Bakker PI, Gabriel SB, Mirel DB, Ivinson AJ, Pericak-Vance MA, Gregory SG, Rioux JD, McCauley JL, Haines JL, Barcellos LF, Cree B, Oksenberg JR, Hauser SL. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007;357:851-62.
2. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009;41: 824-8.
3. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, Potter SC, Goris A, Band G, Oturai AB, Strange A, Saarela J, Bellenguez C, Fontaine B, Gillman M, Hemmer B, Gwilliam R, Zipp F, Jayakumar A, Martin R, Leslie S, Hawkins S, Giannoulatou E, D'alfonso S, Blackburn H, Martinelli Boneschi F, Liddle J, Harbo HF, Perez ML, Spurkland A, Waller MJ, Mycko MP, Ricketts M, Comabella M, Hammond N, Kockum I, McCann OT, Ban M, Whittaker P, Kemppinen A, Weston P, Hawkins C, Widaa S, Zajicek J, Dronov S, Robertson N, Bumpstead SJ, Barcellos LF, Ravindrarajah R, Abraham R, Alfredsson L, Ardlie K, Aubin C, Baker A, Baker K, Baranzini SE, Bergamaschi L, Bergamaschi R, Bernstein A, Berthele A, Boggild M, Bradfield JP, Brassat D, Broadley SA, Buck D, Butzkueven H, Capra R, Carroll WM, Cavalla P, Celius EG, Cepok S, Chiavacci R, Clerget-Darpoux F, Clysters K, Comi G, Cossburn M, Cournu-Rebeix I, Cox MB, Cozen W, Cree BA, Cross AH, Cusi D, Daly MJ, Davis E, de Bakker PI, Debouverie M, D'hooghe MB, Dixon K, Dobosi R, Dubois B, Ellinghaus D, Elovaara I, Esposito F, Fontenille C, Foote S, Franke A, Galimberti D, Ghezzi A, Glessner J, Gomez R, Gout O, Graham C, Grant SF, Guerini FR, Hakonarson H, Hall P, Hamsten A, Hartung HP, Heard RN, Heath S, Hobart J, Hoshi M, Infante-Duarte C, Ingram G, Ingram W, Islam T, Jagodic M, Kabesch M, Kermode AG, Kilpatrick TJ, Kim C, Klopp N, Koivisto K, Larsson M, Lathrop M, Lechner-Scott JS, Leone MA, Leppä V, Liljedahl U, Bomfim IL, Lincoln RR, Link J, Liu J, Lorentzen AR, Lupoli S, Macciardi F, Mack T, Marriott M, Martinelli V, Mason D, McCauley JL, Mentch F, Mero IL, Mihalova T, Montalban X, Mottershead J, Myhr KM, Naldi P, Ollier W, Page A, Palotie A, Pelletier J, Piccio L, Pickersgill T, Piehl F, Pobywajlo S, Quach HL, Ramsay PP, Reunanen M, Reynolds R, Rioux JD, Rodegher M, Roesner S, Rubio JP, Rückert IM, Salvetti M, Salvi E, Santaniello A, Schaefer CA, Schreiber S, Schulze C, Scott RJ, Sellebjerg F, Selmaj KW, Sexton D, Shen L, Simms-Acuna B, Skidmore S, Sleiman PM, Smestad C, Sørensen PS, Søndergaard HB, Stankovich J, Strange RC, Sulonen AM, Sundqvist E, Syvänen AC, Taddeo F, Taylor B, Blackwell JM, Tienari P, Bramon E, Tourbah A, Brown MA, Tronczynska E, Casas JP, Tubridy N, Corvin A, Vickery J, Jankowski J, Villoslada P, Markus HS, Wang K, Mathew CG, Wason J, Palmer CN, Wichmann HE, Plomin R, Willoughby E, Rautanen A, Winkelmann J, Wittig M, Trembath RC, Yaouanq J, Viswanathan AC, Zhang H, Wood NW, Zuvich R, Deloukas P, Langford C, Duncanson A, Oksenberg JR, Pericak-Vance MA, Haines JL, Olsson T, Hillert J, Ivinson AJ, De Jager PL, Peltonen L, Stewart GJ, Hafler DA, Hauser SL, McVean G, Donnelly P, Compston A, International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011;476:214-19.
4. Wise LH, Lanchbury JS, Lewis CM. Meta-analysis of genome searches. Ann Hum Genet 1999;63(Pt 3):263-72.
5. Verghese PB, Castellano JM, Holtzman DM. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol 2011;10:241-52.
6. Burwick RM, Ramsay PP, Haines JL, Hauser SL, Oksenberg JR, Pericak-Vance MA, Schmidt S, Compston A, Sawcer S, Cittadella R, Savettieri G, Quattrone A, Polman CH, Uitdehaag BM, Zwemmer JN, Hawkins CP, Ollier WE, Weatherby S, Enzinger C, Fazekas F, Schmidt H, Schmidt R, Hillert J, Masterman T, Hogh P, Niino M, Kikuchi S, Maciel P, Santos M, Rio ME, Kwiecinski H, Zakrzewska-Pniewska B, Evangelou N, Palace J, Barcellos LF. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers. Neurology 2006;66:1373-83.
7. Xuan C, Zhang B-B, Li M, Deng K-F, Yang T, Zhang X-E. No association between APOE ε 4 allele and multiple sclerosis susceptibility: a meta-analysis from 5472 cases and 4727 controls. J Neurol Sci 2011;308:110-16.
8. Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F, Radue EW, Lindberg RL, Uitdehaag BM, Johnson MR, Angelakopoulou A, Hall L, Richardson JC, Prinjha RK, Gass A, Geurts JJ, Kragt J, Sombekke M, Vrenken H, Qualley P, Lincoln RR, Gomez R, Caillier SJ, George MF, Mousavi H, Guerrero R, Okuda DT, Cree BA, Green AJ, Waubant E, Goodin DS, Pelletier D, Matthews PM, Hauser SL, Kappos L, Polman CH, Oksenberg JR. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 2009;18:767-78.
9. De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT, Piccio L, Raychaudhuri S, Tran D, Aubin C, Briskin R, Romano S; International MS Genetics Consortium, Baranzini SE, McCauley JL, Pericak-Vance MA, Haines JL, Gibson RA, Naeglin Y, Uitdehaag B, Matthews PM, Kappos L, Polman C, McArdle WL, Strachan DP, Evans D, Cross AH, Daly MJ, Compston A, Sawcer SJ, Weiner HL, Hauser SL, Hafler DA, Oksenberg JR. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 2009;41:776-82.
10. Esposito F, Reischl J, Lehr S, Bauer D, Heubach J, Sandbrink R, Pohl C, Edan G, Kappos L, Miller D, Montalbán J, Polman CH, Freedman MS, Hartung HP, Arnason BG, Comi G, Cook S, Filippi M, Goodin DS, Jeffery D, O'Connor P, Ebers GC, Langdon D, Reder AT, Traboulsee A, Zipp F, Schimrigk S, Hillert J, Bahlo M, Booth DR, Broadley S, Brown MA, Browning BL, Browning SR, Butzkueven H, Carroll WM, Chapman C, Foote SJ, Griffiths L, Kermode AG, Kilpatrick TJ, Lechner-Scott J, Marriott M, Mason D, Moscato P, Heard RN, Pender MP, Perreau VM, Perera D, Rubio JP, Scott RJ, Slee M, Stankovich J, Stewart GJ, Taylor BV, Tubridy N, Willoughby E, Wiley J, Matthews P, Boneschi FM, Compston A, Haines J, Hauser SL, McCauley J, Ivinson A, Oksenberg JR, Pericak-Vance M, Sawcer SJ, De Jager PL, Hafler DA, de Bakker PI, Patsopoulos NA. Bayer Pharma MS Genetics Working Group, Steering Committees of Studies Evaluating IFNβ-1b and a CCR1-Antagonist, ANZgene Consortium; GeneMSA; International Multiple Sclerosis Genetics Consortium. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 2011;70:897-912.
11. van der Walt A, Stankovich J, Bahlo M, Taylor BV, van der Mei IA, Foote SJ, Kilpatrick TJ, Rubio JP, Butzkueven H. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy. Neurology 2009;73:1018-25.